JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
J B Chemicals held its Q4 FY26 earnings call, discussing an operational reset that impacted Q4 performance. Management expects normalization from Q1 FY27 and gradual recovery in both India and International businesses, with the merger process with Torrent Pharma in its final stages.
May 13 2026 14:05:00
JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
J B Chemicals and Pharmaceuticals has made available the audio recording of its investors and analysts conference call for the fourth quarter ended March 31, 2026, on its website. This recording provides insights into the company's Q4 FY26 results and recent developments.
May 12 2026 14:05:00
JB Chemicals & Pharmaceuticals Ltd - 506943 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
J. B. Chemicals & Pharmaceuticals Limited disclosed it does not qualify as a 'Large Corporate' entity under the SEBI circular for fund raising via debt securities. This means the company is not subject to specific disclosure requirements applicable to such entities.
May 11 2026 23:05:00
JB Chemicals & Pharmaceuticals Ltd - 506943 - Corporate Action-Board approves Dividend
J.B. Chemicals Board recommended a final dividend of ₹9.30 per equity share for FY 2025-26. This 930% dividend on Re. 1 face value will be paid within 30 days of shareholder approval at the AGM.
May 11 2026 21:05:00
JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
J.B. Chemicals reported Q4 FY26 revenue of Rs.904 cr, down 5% YoY, and net profit of Rs.101 cr, down 30% YoY. Full-year FY26 revenue grew 6% to Rs.4,148 cr.
May 11 2026 21:05:00
JB Chemicals & Pharmaceuticals Ltd - 506943 - Board Meeting Intimation for Meeting Of The Board Of Directors Will Be Held On May 11, 2026
J B Chemicals Board meeting scheduled for May 11, 2026. The agenda includes approval of standalone and consolidated audited financial results for Q4 FY26 and the full financial year, along with a recommendation for a final dividend for FY 2025-26.
May 05 2026 15:05:00
JB Chemicals & Pharmaceuticals Ltd - 506943 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
J B Chemicals & Pharmaceuticals' Equity Shareholders approved the Scheme of Amalgamation with Torrent Pharmaceuticals Limited. The resolution was passed via remote e-voting and e-voting at the NCLT convened meeting held on April 28, 2026.
Apr 28 2026 23:04:00
Read More